Dr. Lu got his PhD from Hong Kong Baptist University. He spent 3 years at the Icahn School of Medicine at Mount Sinai for postdoctoral training before joining the University of Macau as an assistant professor. Dr. Lu is an expert in neurobiology, cell biology, and pharmacology. His major research interests are autophagy in human diseases, and the pharmacological study of traditional Chinese medicine. Dr. Lu tries to combine biochemistry, cell biology, and neurobiology approaches, and to apply cell, fruit fly, and transgenic mouse models to identify small molecular autophagy modulators with therapeutic potential for human diseases, including neurodegenerative and inflammatory diseases, as well as cancer. Dr. Lu has published a series of papers as a first author or corresponding author in high-profile journals, including: Nature Communications, Autophagy (5), Molecular Neurodegeneration, Acta Pharmaceutica Sinica B, Cell death and disease (2), with over 5,500 total citations (WoS).